← 返回

转移性病灶切除术在获取 TIL(肿瘤浸润淋巴细胞)用于采集及生物标志物/基因组检测中的作用

英文原题:Role of Metastasectomy for Tissue Acquisition for Tumor-Infiltrating Lymphocyte Harvest and Biomarker/Genomic Testing.

查看英文原题

Role of Metastasectomy for Tissue Acquisition for Tumor-Infiltrating Lymphocyte Harvest and Biomarker/Genomic Testing.

PubMed 2024/12/13(内容时间) Thorac Surg Clin Q3 · IF 1.6(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

TIL(肿瘤浸润淋巴细胞)疗法是一种新兴的治疗模式,在缺乏许多良好替代方案的患者群体中显示出有希望的早期结果。在某些无法获取原发肿瘤或软组织转移灶的情况下,胸外科医生可能可以发挥作用,从肺转移灶中获取组织。通常,这些可以是局限性切除,大多数病例适合楔形切除,因为通常只需要1 cm的组织。因此,在适当选择的患者中,已显示肺部、心血管、感染和伤口并发症的风险较低。

展开英文摘要原文

Tumor-infiltrating lymphocyte therapy is an emerging paradigm with promising early results for a patient population without many good alternatives. In some cases where the primary tumor or soft tissues metastases cannot be harvested, there may be a role for the thoracic surgeon to harvest tissue from pulmonary metastases.

Typically, these can be limited resections with most cases being amenable to a wedge resection as only 1 cm of tissue is usually required. As a result, in appropriately selected patients, there has been shown to be a low risk of pulmonary, cardiovascular, infectious, and wound complications.

论文信息

作者
Huang K、Bostock IC
第一作者单位
Department of Surgery, Medical University of South Carolina, 171 Ashley Avenue, Charleston, SC 29425, USA.United States
通讯作者单位
Department of Thoracic Surgery, Miami Cancer Institute, Baptist Health South Florida, 8900 N Kendall Drive, Miami, FL 33176, USA. Electronic address: bostock.ian@gmail.com.United States
文献类型
综述
期刊
Thoracic surgery clinics2025 May
原文标识
PubMed 40246406 · DOI 10.1016/j.thorsurg.2024.11.010